유럽의 바이오 제조 바이러스 검출 및 정량화 시장 : 분석과 예측(2023-2032년)

“The Europe Biomanufacturing Viral Detection and Quantification Market Expected to Reach $345.9 Million by 2032.”

Introduction to Europe Biomanufacturing Viral Detection and Quantification Market

The Europe biomanufacturing viral detection and quantification market was valued at $137.3 million in 2022 and is anticipated to reach $345.9 million by 2032, witnessing a CAGR of 9.80% during the forecast period 2023-2032. The growing use of biopharmaceutical products and improvements in viral testing technologies are expected to drive the growth of the biomanufacturing viral detection and quantification market in the European market.

Market Introduction

The market for viral detection and quantification biomanufacturing in Europe is expanding quickly as a result of the growing use of biopharmaceutical products. Ensuring the safety, efficacy, and consistency of these products becomes increasingly important as the demand for biologics develops. Sturdy quality control procedures are necessary to comply with regulations and preserve product integrity. One such procedure is the measurement of viral contamination during biomanufacturing. As a result, the European biomanufacturing viral detection and quantification market is experiencing a surge in demand for consumables and instruments. With technological improvements and a commitment to upholding high standards, the market is well-positioned for ongoing growth in the area.

Market Segmentation:

Segmentation 1: by Offering Type

• Consumables
• Instruments
• Services

Segmentation 2: by Technology

• PCR
• ELISA
• Flow Cytometry
• Plaque Assay
• Others

Segmentation 3: by Application

• Blood and Blood Products Manufacturing
• Vaccines and Therapeutics Manufacturing
• Cellular and Gene Therapy Products Manufacturing
• Stem Cell Products Manufacturing
• Tissue and Tissue Products Manufacturing

Segmentation 4: by End User

• Life Science Companies
• Testing Laboratories
• CROs and CDMOs

Segmentation 6: by Country

• Germany
• France
• U.K.
• Spain
• Italy
• Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.

Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.

Competitive Strategy: Key players in the Europe biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the Europe biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.

Some of the prominent names in this market are:

Table of Contents

1 Product Definition

• 1.1 Inclusion and Exclusion Criteria

2 Market Scope

• 2.1 Key Questions Answered in the Report

3 Research Methodology

4 Europe

• 4.1 Overview
• 4.2 Europe
  • 4.2.1 Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
  • 4.2.2 Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
  • 4.2.3 Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
  • 4.2.4 Europe Biomanufacturing Viral Detection and Quantification Market (by End User)
  • 4.2.5 Europe Biomanufacturing Viral Detection and Quantification Market (by Country)
    • 4.2.5.1 Germany
      • 4.2.5.1.1 Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 4.2.5.1.2 Germany Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 4.2.5.1.3 Germany Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 4.2.5.1.4 Germany Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 4.2.5.2 U.K.
      • 4.2.5.2.1 U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 4.2.5.2.2 U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 4.2.5.2.3 U.K. Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 4.2.5.2.4 U.K. Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 4.2.5.3 France
      • 4.2.5.3.1 France Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 4.2.5.3.2 France Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 4.2.5.3.3 France Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 4.2.5.3.4 France Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 4.2.5.4 Spain
      • 4.2.5.4.1 Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 4.2.5.4.2 Spain Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 4.2.5.4.3 Spain Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 4.2.5.4.4 Spain Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 4.2.5.5 Italy
      • 4.2.5.5.1 Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 4.2.5.5.2 Italy Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 4.2.5.5.3 Italy Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 4.2.5.5.4 Italy Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 4.2.5.6 Rest-of-Europe
      • 4.2.5.6.1 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 4.2.5.6.2 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 4.2.5.6.3 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 4.2.5.6.4 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User)

5 Markets - Competitive Benchmarking & Company Profiles

• 5.1 Overview
• 5.2 Company Share Analysis
• 5.3 Biomanufacturing Viral Detection and Quantification Ecosystem Active Players
• 5.4 Merck KGaA
  • 5.4.1 Company Overview
  • 5.4.2 Role of Merck KGaA in the Biomanufacturing Viral Detection and Quantification Market
  • 5.4.3 Key Competitors
  • 5.4.4 Financials
  • 5.4.5 Key Insights about the Financial Health of the Company
  • 5.4.6 Analyst Perspective
• 5.5 Sartorius AG
  • 5.5.1 Company Overview
  • 5.5.2 Role of Sartorius AG in the Biomanufacturing Viral Detection and Quantification Market
  • 5.5.3 Key Competitors
  • 5.5.4 Financials
  • 5.5.5 Analyst Perspective
• 5.6 QIAGEN N.V.
  • 5.6.1 Company Overview
  • 5.6.2 Role of QIAGEN N.V. in the Biomanufacturing Viral Detection and Quantification Market
  • 5.6.3 Key Competitors
  • 5.6.4 Financials
  • 5.6.5 Key Insights about the Financial Health of the Company
  • 5.6.6 Analyst Perspective